163 related articles for article (PubMed ID: 28922292)
1. Advances in delivery of ambulatory autologous stem cell transplantation for multiple myeloma.
Khouri J; Majhail NS
Curr Opin Support Palliat Care; 2017 Dec; 11(4):361-365. PubMed ID: 28922292
[TBL] [Abstract][Full Text] [Related]
2. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
[TBL] [Abstract][Full Text] [Related]
3. Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.
Martino M; Lemoli RM; Girmenia C; Castagna L; Bruno B; Cavallo F; Offidani M; Scortechini I; Montanari M; Milone G; Postacchini L; Olivieri A
Bone Marrow Transplant; 2016 Aug; 51(8):1032-40. PubMed ID: 27042841
[TBL] [Abstract][Full Text] [Related]
4. Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study.
Martino M; Montanari M; Ferrara F; Ciceri F; Scortechini I; Palmieri S; Marktel S; Cimminiello M; Messina G; Irrera G; Offidani M; Console G; Castagna L; Milone G; Bruno B; Tripepi G; Lemoli RM; Olivieri A;
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1026-32. PubMed ID: 24699116
[TBL] [Abstract][Full Text] [Related]
5. Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.
Holbro A; Ahmad I; Cohen S; Roy J; Lachance S; Chagnon M; LeBlanc R; Bernard L; Busque L; Roy DC; Sauvageau G; Kiss TL
Biol Blood Marrow Transplant; 2013 Apr; 19(4):547-51. PubMed ID: 23253556
[TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
Gertz MA; Ansell SM; Dingli D; Dispenzieri A; Buadi FK; Elliott MA; Gastineau DA; Hayman SR; Hogan WJ; Inwards DJ; Johnston PB; Kumar S; Lacy MQ; Leung N; Micallef IN; Porrata LF; Schafer BA; Wolf RC; Litzow MR
Mayo Clin Proc; 2008 Oct; 83(10):1131-8. PubMed ID: 18828972
[TBL] [Abstract][Full Text] [Related]
7. A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Martino M; Ciavarella S; De Summa S; Russo L; Meliambro N; Imbalzano L; Gallo GA; Moscato T; Messina G; Ferreri A; Cuzzola M; Irrera G; Naso V; Cimminiello M; Console G; Loseto G; Tommasi S; Guarini A
Biol Blood Marrow Transplant; 2018 Mar; 24(3):608-613. PubMed ID: 29032271
[TBL] [Abstract][Full Text] [Related]
8. Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis.
Ferrara F; Izzo T; Criscuolo C; Riccardi C; Viola A; Delia R; Carbone A; Celentano M
Hematol Oncol; 2011 Sep; 29(3):139-43. PubMed ID: 21922508
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
[TBL] [Abstract][Full Text] [Related]
10. Relapsed multiple myeloma: who benefits from salvage autografts?
Chow AW; Lee CH; Hiwase DK; To LB; Horvath N
Intern Med J; 2013 Feb; 43(2):156-61. PubMed ID: 22757772
[TBL] [Abstract][Full Text] [Related]
11. The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation.
Martino M; Pitino A; Tripepi G; Paviglianiti A; Russo L; Cusumano G; Rossetti A; Provenzano PF; Porto G; Meliambro N; Gallo S; Porcino D; Romeo V; Gangemi T; D'Arrigo G; Imbalzano L; Console G; Gori M
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e402-e409. PubMed ID: 33288484
[TBL] [Abstract][Full Text] [Related]
12. Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma.
Ferrara F; Palmieri S; Viola A; Copia C; Schiavone EM; De Simone M; Pocali B; D'Amico MR; Annunziata M; Mele G
Hematol J; 2004; 5(3):222-6. PubMed ID: 15167908
[TBL] [Abstract][Full Text] [Related]
13. [Single vs double stem cell transplantation for the treatment of multiple myeloma].
Tamura H
Nihon Rinsho; 2015 Jan; 73(1):85-9. PubMed ID: 25626310
[TBL] [Abstract][Full Text] [Related]
14. Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.
Yip HM; Yong K; De-Silva D; Rabin N
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):160-162. PubMed ID: 32192978
[TBL] [Abstract][Full Text] [Related]
15. Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art.
Martino M; Paviglianiti A; Memoli M; Martinelli G; Cerchione C
Front Oncol; 2020; 10():592487. PubMed ID: 33262948
[TBL] [Abstract][Full Text] [Related]
16. Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
Kodad SG; Sutherland H; Limvorapitak W; Abou Mourad Y; Barnett MJ; Forrest D; Gerrie A; Hogge DE; Nantel SH; Narayanan S; Nevill T; Power M; Sanford D; Toze C; White J; Broady R; Song K
Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):784-790. PubMed ID: 31678079
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry.
Cook G; Liakopoulou E; Pearce R; Cavet J; Morgan GJ; Kirkland K; Lee J; Davies FE; Hall R; Rahemtulla A; Russell N; Marks DI;
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1638-45. PubMed ID: 21565277
[TBL] [Abstract][Full Text] [Related]
18. Second autologous transplant as salvage therapy in multiple myeloma.
Atanackovic D; Schilling G
Br J Haematol; 2013 Dec; 163(5):565-72. PubMed ID: 24111632
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation beyond 60 years of age.
Jantunen E
Bone Marrow Transplant; 2006 Dec; 38(11):715-20. PubMed ID: 17041609
[TBL] [Abstract][Full Text] [Related]
20. High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Clin Transplant; 2009; 23(6):839-47. PubMed ID: 20447186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
